Companies: 10,795·Total market cap: $144.5T
Mainz Biomed B.V.

Mainz Biomed B.V.

MYNZNASDAQHealthcare
$3.59
+$0.03(+0.84%)
Market Cap$14691084
P/E Ratio
52W High$5.34
52W Low$0.5476

Mainz Biomed B.V.(MYNZ)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MYNZ · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.54M$0.89M$0.90M$0.53M$0.58M
Cost of Revenue$0.76M$0.32M$0.39M$0.35M$0.40M
Gross Profit($0.23M)$0.57M$0.51M$0.18M$0.18M
Gross Margin %(computed)-42.07%64.31%56.91%34.38%30.77%
Operating Expenses
R&D Expenses$4.91M$5.84M$9.59M$3.66M$0.47M
G&A Expenses$5.11M$8.08M$13.42M$17.83M$8.45M
Total Operating Expenses$13.27M$19.27M$27.15M$26.36M$9.56M
Operating Income($13.50M)($18.70M)($26.64M)($26.44M)($9.72M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense($0.37M)$1.08M$0.81M$0.29M$0.34M
Income Before Tax($16.21M)($21.65M)($26.30M)($26.39M)($11.70M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.38M
Net Income($16.21M)($21.65M)($26.30M)($26.45M)($11.69M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.70$-22.36$-1.62$-1.87$-1.67
Wtd Avg Shares6.00M0.97M16.24M14.16M7.21M
EBITDA($12.88M)($19.56M)($25.01M)($25.72M)($11.28M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Mainz Biomed B.V.

关于Mainz Biomed B.V.(MYNZ)损益表

Mainz Biomed B.V.(MYNZ)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MYNZ实现营收$0.00B,毛利润($0.00B)(毛利率-42.07%),净利润($0.02B)(净利率-3018.31%)。

常见问题

MYNZ · 4 问

Mainz Biomed B.V.(MYNZ)2025财年营收为$0.00B,同比down39.9%。

MYNZ revenueMYNZ salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08